Основные мероприятия ассоциации офтальмологов
Ассоциации
профессор
Beaver
YouTube
santen
Конгресс 2014
glaucoma_net_ru
facebook
www.worldglaucoma.org
АйНьюс.РФ
Конгресс
Торика
Флаги
Конгресс
askin_heid
ВК
Mobile
appstore
oftalmolog_club
bannerparasol
varthamana2
Первая пятница декабря
medlab
eye5
Шахматы
Главная / Новости

Новости


1 2 3 4 5 6 7 8 9 10


15 февраля 2017 - Х Российская глаукомная школа, Санкт-Петербург
Полная программа Школы

11 февраля 2017 - Bilateral uveitis after phakic intraocular lens implantation and management with adalimumab
A 25-year-old woman with myopia who had an AC pIOL implantation in the left eye and posterior chamber pIOL implantation in the right eye developed bilateral granulomatous panuveitis 2 months after the second surgery. Physical examination showed bilateral Koeppe and Busacca nodules. Fluorescein angiography showed diffuse vascular and retinal pigment epithelial leakage in both eyes. With assessment of sympathetic ophthalmia, treatment with a high-dose systemic steroid was started. Oral cyclosporine and azathioprine were later added.

08 февраля 2017 - К вопросу о начислении баллов!
Для начисления зачетных единиц, полученных после прохождения обучения в рамках учебного мероприятия (конференция, мастер-класс, заседание профессионального общества), Вам необходимо указать индивидуальный код подтверждения на сайте Координационного совета по развитию непрерывного медицинского и фармацевтического образования Министерства здравоохранения РФ: http://www.sovetnmo.ru.

05 февраля 2017 - Как врачу отказаться от лечения пациента?
1. Лечащий врач по согласованию с руководителем медорганизации может отказаться лечить пациента, если отказ не угрожает жизни больного 2. Решение об отказе нужно передать пациенту либо отправить заказным письмом с уведомлением 3. Если все врачи отказались от наблюдения пациента по предусмотренной законом процедуре, руководитель может предложить гражданину обратиться в иную медорганизацию

03 февраля 2017 - Министерство разработало краткие рекомендации для авторов по подготовке и оформлению научных статей в журналах, индексируемых в международных наукометрических базах данных
Рекомендации детально объясняют публикационный процесс, процедуры рецензирования и опубликования, а также общепринятые требования к структуре научной статьи. Данная информация нацелена на помощь научным работникам и повышение их публикационной активности.

02 февраля 2017 - Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
Purpose: The aim was to evaluate the safety of bilateral same-day injections with intravitreal antiangiogenic drugs for macular diseases. Methods: Cross-sectional retrospective review of unilateral and bilateral same-day antiangiogenic injections was conducted between January 2011 and March 2016 in the Unit of Macula, University and Polytechnic Hospital La Fe (Valencia, Spain). A total of 8,172 injections were administered, among which 6,560 were unilateral and 1,612 were bilateral injections. Patients were included in the study regardless of the diagnosis. Ranibizumab and aflibercept were the antiangiogenic drugs used. The presence of endophthalmitis or retinal detachment was evaluated.

26 января 2017 - Glaucoma: Novel Mechanisms and Treatments that Target the Elusive IOP
Glaucoma is currently the second leading cause of blindness throughout the world. The goal of glaucoma treatment is to stop or slow disease progression. Current glaucoma medications achieve this almost exclusively through reduction of intraocular pressure (IOP). Unfortunately, even with appropriate use of currently available medications, many people with glaucoma will still experience vision loss. Intraocular pressure is the only known modifiable risk factor for patients with glaucoma, so improvements in patient outcomes rely on tight IOP control and patient adherence to therapy. In this educational activity, leading clinicians review established and new therapeutic agents for patients with glaucoma, including the recent clinical evidence for their safety and efficacy. In addition, discussion will comprise the recent evidence concerning the effects of low perfusion pressure on glaucoma development and progression.

25 января 2017 - Who are the ideal patients?
А что Вы думаете по этому поводу?

22 января 2017 - Top Eye Care Stories of 2016
Подробнее внутри!

20 января 2017 - Abstract submission deadline: 10 days left!
The Scientific Committee invites you to participate actively in this congress which will be an extraordinary occasion for the exchange of thoughts and experiences. We look forward to receiving abstracts for consideration and inclusion in the program as oral or poster presentations.

18 января 2017 - Early to Advanced AMD: Defining the Importance of Prompt Diagnosis and Treatment
Management of the geographic atrophy seen in late-stage dry age-related macular degeneration (AMD) poses several challenges. Scientific understanding of geographic atrophy continues to develop, and recent changes have been made to how this condition is classified, which underscores the importance of accurately monitoring progression. Although no treatment has been approved to manage late-stage dry AMD, complement inhibition, visual cycle modulation, neuroprotection, and stem cell therapy have had encouraging results in clinical trials

15 января 2017 - Understanding Corneal Stem Cells Through Stripes
Fusing the embryos of mice, where one contains a marker of its lineage, is a well-established technique in developmental biology research. The stripy corneas were still a surprise, though…

09 января 2017 - Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis
Purpose: To systematically review anatomical and functional outcomes subsequent to switching from bevacizumab/ranibizumab to aflibercept monotherapy in patients with treatment-resistant neovascular age-related macular degeneration (nAMD).

04 января 2017 - Deadline for WGC-2017 abstract & clinical case submission: January 30!
The Scientific Committee invites you to participate actively in this congress which will be an extraordinary occasion for the exchange of thoughts and experiences. We look forward to receiving abstracts for consideration and inclusion in the program as oral or poster presentations

30 декабря 2016 - Applicability of automatic spectral domain optical coherence tomography for glaucoma mass screening
Скоро Новый год, а мы все о глаукоме)

25 декабря 2016 - В новом году разместим на сайте Новости глаукомы
Полный текст будет размещен в 2017 году

23 декабря 2016 - GenSight reports visual acuity gains in phase 1/2 study of GS010 for Leber’s hereditary optic neuropathy
GenSight Biologics reported sustained visual acuity improvement in patients with Leber’s hereditary optic neuropathy who were treated with GS010 in a phase 1/2 clinical trial

22 декабря 2016 - The International Committee of Medical Journal Editors has updated the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.
The International Committee of Medical Journal Editors has updated the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. The updated Recommendations may be found and downloaded at www.icmje.org. To assist in identifying where changes have been made, an annotated copy of the Recommendations is available at our website under “News & Editorials.”

20 декабря 2016 - ICO’s Global Call for Action to Eliminate Surgical Eye Errors
Patient safety is a high priority for the World Health Organization and all of us, and we ask that you support, share, and promote the ICO’s Global Call for Action to Eliminate Surgical Eye Errors

19 декабря 2016 - Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration: Real-World Insights on Optimising Visual Acuity While Reducing Treatment Burden
Anat Loewenstein, MD: Hello, my name is Anat Loewenstein from the Tel Aviv Medical Centre, and the Tel Aviv University in Tel Aviv, Israel. Welcome to this PeerVoice activity on neovascular age-related macular degeneration


1 2 3 4 5 6 7 8 9 10
Голосование
Что "заставляет" Вас заниматься научными исследованиями?